
Join leading experts as they explore the complete preeclampsia management journey - from implementing efficient first-trimester screening workflows with PlGF markers, to evidence-based approaches for aspirin prophylaxis, to the compelling economic and health outcome benefits of early detection programs. These complementary sessions provide practical insights for clinicians seeking to optimize preeclampsia care pathways.
Dr. Mar Gil
Implementation of First Trimester PE Screening with PlGF – Exploring
Efficient Workflows
Professor Liona Poon
Making Sense of Prophylactic Aspirin
– A Risk-Benefit Analysis
Professor Jon Hyett
The Economic and Health Outcome Impact of Preeclampsia Screening
The webinar talks were recorded in April 2025 during HVD LifeSciences' 3rd annual CEE Pre-eclampsia virtual meeting 'Beyond the Clinic'.
Revvity Inc. does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations, please consult your local health care professionals.